Comparison of the Angiotensin 2 Type 1-Receptor Antagonist YM358 and the Angiotensin-Converting Enzyme Inhibitor Enalapril in Rats With Cardiac Volume Overload

DOI Web Site Web Site Web Site PubMed 被引用文献1件 参考文献38件
  • Tokioka-Akagi Tomoko
    Clinical Development Coordination Department, Yamanouchi Pharmaceutical Co., Ltd.
  • Fujimori Akira
    Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
  • Shibasaki Masayuki
    Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
  • Inagaki Osamu
    Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
  • Yanagisawa Isao
    Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.

書誌事項

タイトル別名
  • Comparison of the Angiotensin II Type 1-Receptor Antagonist YM358 and the Angiotensin-Converting Enzyme Inhibitor Enalapril in Rats With Cardiac Volume Overload.

この論文をさがす

説明

We evaluated the effects of chronic oral administration of an angiotensin II type 1 (AT1)-receptor antagonist YM358 and an angiotensin converting enzyme inhibitor enalapril on hemodynamics and cardiac hypertrophy in rats with volume overload-induced heart failure. We assessed changes of cardiac hemodynamics and cardiac hypertrophy at 2 and 4 weeks after administration of YM358 (3, 30 mg/kg per day) or enalapril (30 mg/kg per day) in abdominal aortocaval shunt rats. YM358 (30 mg/kg) attenuated increases of left ventricle (LV)/body weight (BW), left atrium (LA)/BW, right ventricle (RV)/BW and heart/BW ratios, but did not affect cardiac hemodynamics in shunt rats. Enalapril also reduced the increased LV/BW and heart/BW ratios together with significant reductions of systolic blood pressure, left ventricular systolic pressure and the first derivative of left ventricular pressure. These data suggest that the effects on attenuation of the development of cardiac hypertrophy are not different for YM358 and enalapril, although the effects on cardiac hemodynamics are different for the same dosages. The attenuating action of YM358 on cardiac hypertrophy was independent of the action on hemodynamics and indicated the direct action of the AT1 receptor on the heart.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 86 (1), 79-85, 2001

    公益社団法人 日本薬理学会

被引用文献 (1)*注記

もっと見る

参考文献 (38)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ